These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6238549)
1. Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum. Nerenberg C; Foreman J; Chu N; Chaplin MD; Kushinsky S Anal Biochem; 1984 Aug; 141(1):10-6. PubMed ID: 6238549 [TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of detirelix ([ N-Ac-D-Nal(2)1,D-p-Cl-Phe2,D-Trp3, D-hArg(Et)6(2),D-Ala10]-luteinizing hormone-releasing hormone) in plasma or serum. Nerenberg C; LaFargue J; Webb A; Chan R; Kushinsky S J Immunoassay; 1988; 9(3-4):245-55. PubMed ID: 3069871 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of ganirelix in plasma or serum. Nerenberg C; LaFargue J; Gee C; Chu F; Wolfe L; Chan R; Tarnowski T J Immunoassay; 1993 Sep; 14(3):191-207. PubMed ID: 8354719 [TBL] [Abstract][Full Text] [Related]
4. A Radioimmunoassay Procedure for the Determination of the Antiviral Nucleoside DHPG (9-[(l,3-Dihydroxy-2-propoxy)-methyl]guanine) in Plasma or Serum. Nerenberg C; McClung S; Martin J; Fass M; La Fargue J; Kushinsky S Pharm Res; 1986 Apr; 3(2):112-5. PubMed ID: 24271470 [TBL] [Abstract][Full Text] [Related]
5. Identification of major urinary metabolites of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in the rhesus monkey. Chan RL; Chaplin MD Drug Metab Dispos; 1985; 13(5):566-71. PubMed ID: 2865104 [TBL] [Abstract][Full Text] [Related]
6. Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys. Chu NI; Chan RL; Hama KM; Chaplin MD Drug Metab Dispos; 1985; 13(5):560-5. PubMed ID: 2865103 [TBL] [Abstract][Full Text] [Related]
7. Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I. Anik ST; McRae G; Nerenberg C; Worden A; Foreman J; Hwang JY; Kushinsky S; Jones RE; Vickery B J Pharm Sci; 1984 May; 73(5):684-5. PubMed ID: 6234387 [TBL] [Abstract][Full Text] [Related]
8. Plasma binding of LHRH and nafarelin acetate, a highly potent LHRH agonist. Chan RL; Chaplin MD Biochem Biophys Res Commun; 1985 Mar; 127(2):673-9. PubMed ID: 3156598 [TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone--releasing hormone levels in human plasma: a radioimmunoassay method. Aksel S; Glass R Am J Obstet Gynecol; 1979 Jul; 134(6):619-23. PubMed ID: 380341 [TBL] [Abstract][Full Text] [Related]
10. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay of Antarelix, a luteinizing hormone releasing-hormone antagonist, in plasma and its application for pharmacokinetic study in dogs. Sorensen S; Rondeau JJ; Lenaerts V; Boutignon F; Wüthrich P; Deghenghi R; Adam A; Ong H J Immunoassay; 1996 Aug; 17(3):205-26. PubMed ID: 8842981 [TBL] [Abstract][Full Text] [Related]
12. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587 [TBL] [Abstract][Full Text] [Related]
13. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH. Csernus VJ; Szende B; Groot K; Redding TW; Schally AV Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):111-8. PubMed ID: 2110458 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists. Uemura T; Yanagisawa T; Shirasu K; Matsuyama A; Minaguchi H Am J Obstet Gynecol; 1992 Jul; 167(1):283-91. PubMed ID: 1332475 [TBL] [Abstract][Full Text] [Related]
15. Thyrotropin (TSH)-releasing hormone-stimulated TSH release and TSH concentration in the guinea pig pituitary, as determined by a heterologous radioimmunoassay. DeVito WJ; Allen E; Wu CF; Alex S; Emerson CH Endocrinology; 1989 Mar; 124(3):1190-7. PubMed ID: 2492922 [TBL] [Abstract][Full Text] [Related]
16. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin). Andreyko JL; Monroe SE; Jaffe RB J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatography followed by radioimmunoassay for the determination of a luteinizing hormone-releasing hormone analogue, leuprorelin, and its metabolite. Ueno H; Matsuo S J Chromatogr; 1991 May; 566(1):57-66. PubMed ID: 1909342 [TBL] [Abstract][Full Text] [Related]
18. A radioimmunoassay for TA-0910, a new metabolically stable thyrotrophin-releasing hormone analogue. Chishima S J Pharm Biomed Anal; 1994 Jun; 12(6):795-804. PubMed ID: 7918782 [TBL] [Abstract][Full Text] [Related]
19. Detection of functional ovarian hyperandrogenism in women with androgen excess. Ehrmann DA; Rosenfield RL; Barnes RB; Brigell DF; Sheikh Z N Engl J Med; 1992 Jul; 327(3):157-62. PubMed ID: 1319000 [TBL] [Abstract][Full Text] [Related]
20. Validation in rat plasma of a direct radioimmunoassay for a luteinizing hormone-releasing hormone antagonist (BIM 21009). Ezan E; Drieu K; Moreau JP; Dray F J Immunoassay; 1990; 11(3):295-309. PubMed ID: 2229420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]